ArticleCureus2026
Clinical Profile, Radiologic Features, and Clinical Course of Tumefactive Demyelinating Lesions in Two Tertiary Medical Centers in the Philippines: An 11-Year Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tumefactive demyelinating lesions (TDLs) are demyelinating lesions that can mimic tumors on imaging by presenting with mass effect, edema, and ring enhancement. They may be associated with a central demyelinating disease such as multiple sclerosis, neuromyelitis optica, or myelin oligodendrocyte glycoprotein antibody-associated disease. We aimed to determine the clinical, laboratory, and radiologic features, as well as the prognosis, of eight adult patients with TDLs at two tertiary hospitals in the Philippines. We conducted a chart review of patients diagnosed with TDLs from January 2014 to July 2024. Eight patients were diagnosed with TDLs. Most were treated as cases of multiple sclerosis. One tested positive for anti-aquaporin 4 antibody, and another was treated as a case of acute disseminated encephalomyelitis. All patients were given methylprednisolone pulse therapy. The majority of patients had a monophasic course, with symptoms resolving at follow-up. Among Filipino patients, TDLs are rarely diagnosed but mostly have a favorable prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.